scispace - formally typeset
G

Gwynn D. Long

Researcher at Duke University

Publications -  135
Citations -  5370

Gwynn D. Long is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 40, co-authored 129 publications receiving 5141 citations. Previous affiliations of Gwynn D. Long include Durham University & Case Western Reserve University.

Papers
More filters
Journal ArticleDOI

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

TL;DR: The results confirm the efficacy of high-dose therapy and autografting in recurrent or refractory Hodgkin's disease and indicate that a desire to reduce late effects should drive future research efforts in favorable patients whereas new initiatives are needed for those with less favorable prognoses.
Journal ArticleDOI

Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

TL;DR: Hematopoietic growth factors used to accelerate engraftment after bone marrow transplantation and to "mobilize" peripheral blood progenitor cells (PBPC) resulted in a significantly accelerated time to recovery of granulocytes and a statistically significant difference in total costs.
Journal ArticleDOI

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease

TL;DR: The combination of cyclosporine, methotrexate, and prednisone was more effective in preventing acute GVHD of grades II to IV than was the combination of cyclesporine andprednisone without methot Rexate.